Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

31.15
Delayed Data
As of 4:01pm ET
 -0.31 / -0.99%
Today’s Change
28.25
Today|||52-Week Range
37.39
-4.09%
Year-to-Date
Uh-Oh: This Could Be Johnson & Johnson's Biggest Risk in 2017
6:26pm / MotleyFool.com - Paid Partner Content
J&J (JNJ) Q4 Earnings Top; Seeks Options for Diabetes Unit
10:20am / Zacks.com - Paid Partner Content
A Would-Be Dividend Aristocrat With a 3.5% Dividend Yield
5:07pm / GuruFocus News - Paid Partner Content
Here's the Price Where Fallen Angel Bristol-Myers Becomes an Attractive Takeover Targ...
Jan 23 / TheStreet.com - Paid Partner Content
Drugmakers Plan Huge Deals in 2017 -- and Banks Will Collect Big Fees
2:56pm / TheStreet.com - Paid Partner Content
Can Q4 Earnings Revitalize Healthcare ETFs?
Jan 23 / Zacks.com - Paid Partner Content
Sheaff Brock Investment Advisors, LLC Buys CVS Health Corp, United Technologies Corp,...
1:40pm / GuruFocus News - Paid Partner Content
5 Stupendously Expensive Cancer Drugs
Jan 23 / MotleyFool.com - Paid Partner Content
J&J disappoints on 2017 forecasts due to strong dollar
12:30pm / FT.com - Paid Partner Content
M&A-Hungry Nestle Looking at Baby Food Maker Mead Johnson
Jan 23 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close31.46
Today’s open31.40
Day’s range30.90 - 31.46
Volume29,625,416
Average volume (3 months)25,041,427
Market cap$190.9B
Dividend yield4.11%
Data as of 4:01pm ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+9.91%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)-1.52%
P/E ratio31.2
Price/Sales4.13
Price/Book3.00

Competitors

 Today’s
change
Today’s
% change
MRKMerck-0.60-0.97%
NVSNovartis-0.11-0.16%
SNYSanofi-0.49-1.22%
ABBVAbbVie-0.38-0.62%
Data as of 4:02pm ET, 01/24/2017

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.51
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts


Search for Jobs